“Finding a cure for HIV is a formidable challenge to the scientific community. Together with our newest grant recipients, all of whom have a record of excellence in their research, we can take collective steps to help end this devastating epidemic,” said William Lee, PhD, executive vice president of research at Gilead Sciences.
The organizations that received the grants are: San Francisco-based University of California; Worchester-based University of Massachusetts Medical School; Frederick (Md.) National Laboratory for Cancer Research, Aids and Cancer Virus Program, Boston-based Dana-Farber Cancer Institute; and the University of Montpellier’s Institute of Human Genetics in France.
Gilead Sciences also granted more than $22 million for HIV research in January 2017.
More articles on healthcare finance:
Highmark Health, Allegheny Health Network to invest $1B in new hospital, renovations
CMS grants Kansas a 12 month Medicaid extension after an initial request was denied
Columbus Marathon raises $1M for Nationwide Children’s Hospital
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
